These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 21486533)

  • 1. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
    J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.
    Miao X; Sun C; Jiang T; Zheng L; Wang T; Wang S
    J Pharm Pharm Sci; 2011; 14(2):196-214. PubMed ID: 21733409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising dissolution enhancement effect of soluplus on crystallized celecoxib obtained through antisolvent precipitation and high pressure homogenization techniques.
    Homayouni A; Sadeghi F; Varshosaz J; Afrasiabi Garekani H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2014 Oct; 122():591-600. PubMed ID: 25124835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations.
    Guzmán HR; Tawa M; Zhang Z; Ratanabanangkoon P; Shaw P; Gardner CR; Chen H; Moreau JP; Almarsson O; Remenar JF
    J Pharm Sci; 2007 Oct; 96(10):2686-702. PubMed ID: 17518357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the apparent solubility and bioavailability of Tadalafil nanoparticles via antisolvent precipitation.
    Rao Q; Qiu Z; Huang D; Lu T; Zhang ZJ; Luo D; Pan P; Zhang L; Liu Y; Guan S; Li Q
    Eur J Pharm Sci; 2019 Feb; 128():222-231. PubMed ID: 30553058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
    Hu J; Ng WK; Dong Y; Shen S; Tan RB
    Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of microenvironmental pH of nanoparticles for enhanced solubility and oral bioavailability of poorly water-soluble celecoxib.
    Ran Woo M; Bak YW; Cheon S; Suk Kim J; Hun Ji S; Park S; Woo S; Oh Kim J; Giu Jin S; Choi HG
    Int J Pharm; 2024 Jun; 659():124179. PubMed ID: 38692498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micronization of atorvastatin calcium by antisolvent precipitation process.
    Zhang HX; Wang JX; Zhang ZB; Le Y; Shen ZG; Chen JF
    Int J Pharm; 2009 Jun; 374(1-2):106-13. PubMed ID: 19446766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoemulsion: a promising tool for solubility and dissolution enhancement of celecoxib.
    Shakeel F; Faisal MS
    Pharm Dev Technol; 2010; 15(1):53-6. PubMed ID: 19552546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation, characterization, and in vivo evaluation of celecoxib-PVP solid dispersion nanoparticles using supercritical antisolvent process.
    Ha ES; Choo GH; Baek IH; Kim MS
    Molecules; 2014 Dec; 19(12):20325-39. PubMed ID: 25486246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of microcrystal formulation on in vivo absorption of celecoxib in rats.
    Nasr M
    AAPS PharmSciTech; 2013 Jun; 14(2):719-26. PubMed ID: 23543607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced dissolution of celecoxib by supersaturating self-emulsifying drug delivery system (S-SEDDS) formulation.
    Song WH; Park JH; Yeom DW; Ahn BK; Lee KM; Lee SG; Woo HS; Choi YW
    Arch Pharm Res; 2013 Jan; 36(1):69-78. PubMed ID: 23325487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
    Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
    Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
    Ghanavati R; Taheri A; Homayouni A
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric nanoparticles for increased oral bioavailability and rapid absorption using celecoxib as a model of a low-solubility, high-permeability drug.
    Morgen M; Bloom C; Beyerinck R; Bello A; Song W; Wilkinson K; Steenwyk R; Shamblin S
    Pharm Res; 2012 Feb; 29(2):427-40. PubMed ID: 21863477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery system.
    Song WH; Yeom DW; Lee DH; Lee KM; Yoo HJ; Chae BR; Song SH; Choi YW
    Arch Pharm Res; 2014 May; 37(5):626-35. PubMed ID: 23852645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation.
    Dong Y; Ng WK; Shen S; Kim S; Tan RB
    Int J Pharm; 2009 Jun; 375(1-2):84-8. PubMed ID: 19481693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
    Ige PP; Baria RK; Gattani SG
    Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.